| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JHEP.2011.12.025 |
| P698 | PubMed publication ID | 22314419 |
| P50 | author | Jean Woo | Q41590321 |
| Winnie Chiu-Wing Chu | Q51032069 | ||
| P2093 | author name string | Jun Yu | |
| Francis Ka-Leung Chan | |||
| Henry Lik-Yuen Chan | |||
| Grace Lai-Hung Wong | |||
| Vincent Wai-Sun Wong | |||
| Angel Mei-Ling Chim | |||
| Anthony Wing-Hung Chan | |||
| Paul Cheung-Lung Choi | |||
| Hoi-Yun Chan | |||
| David Ka-Wai Yeung | |||
| Jiayun Shen | |||
| P433 | issue | 6 | |
| P921 | main subject | biomarker | Q864574 |
| non-alcoholic steatohepatitis | Q28692677 | ||
| P304 | page(s) | 1363-1370 | |
| P577 | publication date | 2012-02-04 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers | |
| P478 | volume | 56 |
| Q51244039 | A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese: A population-based study. |
| Q103806081 | A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis |
| Q36246821 | Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage |
| Q34247340 | Autophagy and non-alcoholic fatty liver disease. |
| Q28080541 | Biomarkers in nonalcoholic fatty liver disease |
| Q92837793 | Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells |
| Q89238154 | Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease |
| Q35676997 | Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis |
| Q33895173 | Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease |
| Q35064093 | Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis |
| Q33637279 | Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients |
| Q30431186 | Diagnosis of alcoholic liver disease |
| Q37689828 | Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis |
| Q100994723 | Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis |
| Q48171433 | Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease. |
| Q92239278 | FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis |
| Q47150578 | Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid |
| Q37137238 | Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice. |
| Q36413703 | Focus on therapeutic strategies of nonalcoholic Fatty liver disease |
| Q47368100 | Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis |
| Q45745547 | Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease |
| Q90171305 | Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders |
| Q64901221 | HNF1α Controls Liver Lipid Metabolism and Insulin Resistance via Negatively Regulating the SOCS-3-STAT3 Signaling Pathway. |
| Q39658315 | Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients |
| Q30376231 | Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease |
| Q91656658 | In search of new biomarkers for nonalcoholic fatty liver disease |
| Q38725581 | Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver. |
| Q28542723 | Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers |
| Q40501773 | Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study |
| Q55715558 | Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts. |
| Q58602760 | Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design |
| Q90599751 | NAFLD and cardiovascular disease |
| Q26865113 | Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins |
| Q30414504 | Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease |
| Q89558100 | NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet? |
| Q90210121 | Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis |
| Q89216668 | Nonalcoholic fatty liver disease |
| Q30435948 | Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease |
| Q34256132 | Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. |
| Q57173225 | Noninvasive biomarkers in NAFLD and NASH - current progress and future promise |
| Q30432576 | Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future |
| Q38141711 | Noninvasive evaluation of NAFLD. |
| Q91656459 | Noninvasive evaluation of nonalcoholic fatty liver disease |
| Q64068370 | Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice |
| Q43073218 | Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis |
| Q36983514 | Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease |
| Q50956110 | Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress? |
| Q36795373 | Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease |
| Q26781431 | Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD |
| Q26752330 | Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and Disease |
| Q37188048 | Roux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis. |
| Q42789488 | Serum M30 and M65 levels and effects of Ankaferd blood stopper in cerulein induced experimental acute pancreatitis model in rats |
| Q48269557 | Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease |
| Q50946137 | Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease. |
Search more.